Skip to main content
Novonesis A/S (CPH: NSIS.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
404.80
+1.10 (0.27%)
Dec 20, 2024, 4:59 PM CET

Novonesis Revenue

Novonesis had revenue of 915.85M EUR in the quarter ending June 30, 2024, with 61.70% growth. This brings the company's revenue in the last twelve months to 3.04B, up 27.85% year-over-year. In the year 2023, Novonesis had annual revenue of 17.90B with 1.97% growth.

Revenue (ttm)
3.04B EUR
Revenue Growth
+27.85%
P/S Ratio
4.93
Revenue / Employee
450.67K EUR
Employees
6,756
Market Cap
188.08B DKK

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202317.90B346.00M1.97%
Dec 31, 202217.55B2.60B17.40%
Dec 31, 202114.95B939.00M6.70%
Dec 31, 202014.01B-362.00M-2.52%
Dec 31, 201914.37B-16.00M-0.11%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SP Group A/S 2.85B
H+H International A/S 2.70B
Flügger group A/S 2.25B
Scandinavian Investment Group A/S 28.00M
RIAS A/S 319.09M
Hove A/S 176.31M
Novo Nordisk A/S 270.58B
DSV A/S 160.12B
Revenue Rankings

Novonesis News

More News